Literature DB >> 18498346

The influence of CD4 T-cell subsets on control of CD4 T-cell-mediated graft-versus-host disease.

Halima Moncrieffe1, Mark Coles, Brigitta Stockinger.   

Abstract

In this study, we tested the effect of different T-cell subpopulations on antigen driven effector cell expansion in lymphopenic hosts, making use of an experimental model of graft-versus-host disease (GVHD). Fluorescence-activated cell sorted (FACS) naïve CD4 T cells from C57BL/6 mice, transferred into lymphopenic F1 (C57BL/6 x BALB/c) Rag-deficient hosts, proliferated extensively and migrated systemically causing acute GVHD within 4 weeks after transfer. Adoptive hosts of CD4 memory T cells on the other hand developed milder symptoms of GVHD with later onset. T-cell expansion and migration to peripheral sites as well as development of GVHD were prevented when naïve T cells were transferred together with CD4(+) CD25(+) T cells, but co-transfer of memory T cells with naïve T cells could not prevent GVHD, although its onset was delayed. OX40, a costimulatory marker that is upregulated at an early time point after T-cell activation and enhances T-cell proliferation, cytokine secretion and survival, was strongly upregulated during GVH responses. Naïve T cells deficient in OX40 expression caused markedly reduced GVH in onset and severity despite some level of expansion in the adoptive host, suggesting an important role of this molecule in the immune pathology of GVHD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498346      PMCID: PMC2612549          DOI: 10.1111/j.1365-2567.2008.02866.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  57 in total

Review 1.  Regulatory T cells in the control of immune pathology.

Authors:  K J Maloy; F Powrie
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

2.  The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.

Authors:  I Gramaglia; A Jember; S D Pippig; A D Weinberg; N Killeen; M Croft
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

3.  OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells.

Authors:  P R Rogers; J Song; I Gramaglia; N Killeen; M Croft
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

4.  Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease.

Authors:  J R Tschetter; E Mozes; G M Shearer
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

5.  OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival.

Authors:  Allison J Curry; Jo Chikwe; Xin G Smith; Ming Cai; Herbert Schwarz; J Andrew Bradley; Eleanor M Bolton
Journal:  Transplantation       Date:  2004-09-27       Impact factor: 4.939

6.  Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease.

Authors:  Benny J Chen; Xiuyu Cui; Gregory D Sempowski; Congxiao Liu; Nelson J Chao
Journal:  Blood       Date:  2003-10-09       Impact factor: 22.113

7.  Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses.

Authors:  Jinfang Zhu; Booki Min; Jane Hu-Li; Cynthia J Watson; Alex Grinberg; Qi Wang; Nigel Killeen; Joseph F Urban; Liying Guo; William E Paul
Journal:  Nat Immunol       Date:  2004-10-10       Impact factor: 25.606

Review 8.  Graft-versus-leukemia reactions in allogeneic chimeras.

Authors:  Hans-Jochem Kolb; Christoph Schmid; A John Barrett; Dolores J Schendel
Journal:  Blood       Date:  2003-09-04       Impact factor: 22.113

Review 9.  Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells.

Authors:  P Lane
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

10.  Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  Petra Hoffmann; Joerg Ermann; Matthias Edinger; C Garrison Fathman; Samuel Strober
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

View more
  4 in total

1.  Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.

Authors:  Yasuyuki Arai; Tadakazu Kondo; Hirohito Yamazaki; Katsuto Takenaka; Junichi Sugita; Takeshi Kobayashi; Yukiyasu Ozawa; Naoyuki Uchida; Koji Iwato; Naoki Kobayashi; Yoshiyuki Takahashi; Ken Ishiyama; Takahiro Fukuda; Tatsuo Ichinohe; Yoshiko Atsuta; Takehiko Mori; Takanori Teshima
Journal:  Haematologica       Date:  2016-02-08       Impact factor: 9.941

Review 2.  Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.

Authors:  Leslie S Kean; Laurence A Turka; Bruce R Blazar
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

3.  Expansion and activation kinetics of immune cells during early phase of GVHD in mouse model based on chemotherapy conditioning.

Authors:  Behnam Sadeghi; Suleiman Al-Hashmi; Zuzana Hassan; Bjorn Rozell; Hernan Concha; Carin Lundmark; Kjell-Olov Grönvik; Manuchehr Abedi-Valugerdi; Moustapha Hassan
Journal:  Clin Dev Immunol       Date:  2010-12-21

4.  Allogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease.

Authors:  Tereza Martinu; Christine V Kinnier; Jesse Sun; Francine L Kelly; Margaret E Nelson; Stavros Garantziotis; W Michael Foster; Scott M Palmer
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.